Both in Pharmaceuticals
Pacira BioSciences vs AnaptysBio
Over the past year PCRX returned +60.1% and ANAB returned +46.5%; their daily moves had a correlation of 0.09.
PCRX +60.1% ANAB +46.5%Growth of $1, one year, split-adjusted
| Metric | PCRX | ANAB |
|---|---|---|
| Price | $36.40 | $46.67 |
| Market cap | $1.45B | $1.40B |
| Today | +0.25% | +2.37% |
| 1 month | +51.2% | −14.6% |
| 6 months | +55.4% | −31.3% |
| Year to date | +40.6% | −3.7% |
| 1 year | +63.5% | +43.8% |
| Revenue growth (YoY) | +6.2% | −8.0% |
| Gross margin | 77.0% | 100.0% |
| Net margin | 2.4% | −206.9% |
| P/E (TTM) | 99.2× | — |
| Price / sales | 1.9× | 6.0× |
| Net cash | -$112.1M | $286.5M |
| Dividend yield | — | — |
| Volatility (60d) | 82.8% | 35.6% |
| Short % of float | 21.2% | 30.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).